68 related articles for article (PubMed ID: 33411160)
21. Average and Interindividual Effects to a Comprehensive Cardiovascular Rehabilitation Program.
Tuesta M; Alvarez C; Pedemonte O; Araneda OF; Manríquez-Villarroel P; Berthelon P; Reyes A
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612584
[TBL] [Abstract][Full Text] [Related]
22. Saudi Heart Association Guidelines on Best Practices in the Management of Chronic Coronary Syndromes.
AlShammeri O; Al Saif S; Al Shehri H; Alasng M; Qaddoura F; Al Shehri M; Turkistani Y; Tash A; Alharbi W; Al Qahtani F; Diaz R; Mahaimeed W; Al Habeeb W; Alfaraidy K
J Saudi Heart Assoc; 2022; 34(3):182-211. PubMed ID: 36578770
[TBL] [Abstract][Full Text] [Related]
23. Exercise capacity and its determinants among postcardiac rehabilitation patients with coronary heart disease.
Chair SY; Leung KC; Lo SWS; Wang Q; Sit JWH; Leung SY; Cheng HY
Nurs Open; 2023 Apr; 10(4):2501-2507. PubMed ID: 36444708
[TBL] [Abstract][Full Text] [Related]
24. Effect of a phase 2 cardiac rehabilitation program on obese and non-obese patients with stable coronary artery disease.
El Missiri A; Abdel Halim WA; Almaweri AS; Mohamed TR
Egypt Heart J; 2021 Jan; 73(1):4. PubMed ID: 33411160
[TBL] [Abstract][Full Text] [Related]
25. Effects of cardiac rehabilitation and exercise training in obese patients with coronary artery disease.
Lavie CJ; Milani RV
Chest; 1996 Jan; 109(1):52-6. PubMed ID: 8549217
[TBL] [Abstract][Full Text] [Related]
26. The obesity paradox, weight loss, and coronary disease.
Lavie CJ; Milani RV; Artham SM; Patel DA; Ventura HO
Am J Med; 2009 Dec; 122(12):1106-14. PubMed ID: 19682667
[TBL] [Abstract][Full Text] [Related]
27. The effect of the cardiac rehabilitation program on obese and non-obese females with coronary heart disease.
Ghashghaei FE; Sadeghi M; Mostafavi S; Heidari H; Sarrafzadegan N
Adv Biomed Res; 2012; 1():17. PubMed ID: 23210076
[TBL] [Abstract][Full Text] [Related]
28. Gender differences among ischemic heart disease patients enrolled in a cardiac rehabilitation program.
El Missiri AM; Awadalla HM; Almoudi MM
Egypt Heart J; 2020 Mar; 72(1):15. PubMed ID: 32232591
[TBL] [Abstract][Full Text] [Related]
29. Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study.
Filippatos TD; Kiortsis DN; Liberopoulos EN; Georgoula M; Mikhailidis DP; Elisaf MS
Curr Med Res Opin; 2005 Dec; 21(12):1997-2006. PubMed ID: 16368051
[TBL] [Abstract][Full Text] [Related]
30. Benefits of Cardiac Rehabilitation in Coronary Artery Disease: DOES WEIGHT MATTER?
Braga M; Nascimento H; Pinto R; Araújo P; Nunes A; Rodrigues J; Araújo V; Parada-Pereira F; Maciel MJ; Rocha A
J Cardiopulm Rehabil Prev; 2019 Nov; 39(6):386-390. PubMed ID: 31688510
[TBL] [Abstract][Full Text] [Related]
31. Effects of Exercise-Based Cardiac Rehabilitation in Patients with Acute Coronary Syndrome: A Meta-Analysis.
Ji H; Fang L; Yuan L; Zhang Q
Med Sci Monit; 2019 Jul; 25():5015-5027. PubMed ID: 31280281
[TBL] [Abstract][Full Text] [Related]
32. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
J Am Coll Cardiol; 2019 Sep; 74(10):e177-e232. PubMed ID: 30894318
[No Abstract] [Full Text] [Related]
33. Obesity: global epidemiology and pathogenesis.
Blüher M
Nat Rev Endocrinol; 2019 May; 15(5):288-298. PubMed ID: 30814686
[TBL] [Abstract][Full Text] [Related]
34. Obesity and its cardiovascular effects.
Ortega-Loubon C; Fernández-Molina M; Singh G; Correa R
Diabetes Metab Res Rev; 2019 May; 35(4):e3135. PubMed ID: 30715772
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
